|
US2015260731A1
|
|
Antibodies, kit and method for detecting amyloid beta oligomers
|
|
US2013089537A1
|
|
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
|
CA2707309A1
|
|
Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
|
|
EP2194975A2
|
|
METHODS OF INHIBITING THE FORMATION OF AMYLOID-ß DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS
|
|
US2011098309A1
|
|
Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
|
|
MX2010000368A
|
|
METHODS OF MODIFYING AMYLOID beta OLIGOMERS USING NON-PEPTIDIC COMPOUNDS.
|
|
MX2010000369A
|
|
Methods of enhancing cognitive function using non-peptidic compounds.
|
|
US2007264669A1
|
|
Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance
|
